TIDMAPH

RNS Number : 8859Y

Alliance Pharma PLC

06 January 2020

 
 For immediate release   6 January 2020

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Block Listing Six Monthly Return

 
 Name of applicant:                                     ALLIANCE PHARMA PLC 
 Names of schemes:                                      a) The Alliance Pharma plc Approved Share Option Plan 2005 
                                                         b) The Alliance Pharma plc Share Option Plan 2006 
                                                         c) The Alliance Pharma plc Company Share Option Plan 2015 
                                                       --------------------------------------------------------------- 
 Period of return:              From:                   28 June 2019             To:      28 December 2019 
                               ----------------------  -----------------------  -------  ----------------------------- 
 Number of securities originally admitted at date of    25,000,000 ordinary shares of 1p each 
 admission:                                              28 June 2017 
                                                       --------------------------------------------------------------- 
 Balance of unallotted securities under schemes from    a) 983,541 
 previous return:                                        b) 15,345,688 
                                                         a) 1,226,097 
                                                       --------------------------------------------------------------- 
 Plus: The amount by which the block schemes have       a) Nil 
 been increased since the date of the last               b) Nil 
 return (if any increase has been applied for):          c) Nil 
                                                       --------------------------------------------------------------- 
 Less: Number of securities issued/allotted under       a) 434,467 
 schemes during period:                                  b) 9,234,354 
                                                         c) 588,621 
                                                       --------------------------------------------------------------- 
 Equals: Balance under schemes not yet                  a) 549,074 
 issued/allotted at end of period:                       b) 6,111,334 
                                                         c) 637,576 
                                                       --------------------------------------------------------------- 
 
 
 
 Name of contact:               Chris Chrysanthou, Company Secretary 
 Telephone number of contact:   Tel. +44 (0)1249 705166 
                               -------------------------------------

For further information:

Buchanan + 44 (0) 20 7466 5000

Mark Court / Hannah Ratcliff

Numis Securities Limited + 44 (0) 20 7260 1000

Nominated Adviser: Freddie Barnfield / Huw Jeremy

Corporate Broking: James Black

Investec Bank plc +44 (0) 20 7597 5970

Corporate Finance: Daniel Adams / Ed Thomas

Corporate Broking: Patrick Robb / Tejas Padalkar

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international specialty pharmaceutical group based in Chippenham, Wiltshire, UK. The Group has sales in more than 100 countries worldwide via direct sales, joint ventures and a wide network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Group continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRKKABPNBKDADK

(END) Dow Jones Newswires

January 06, 2020 08:58 ET (13:58 GMT)

Grafico Azioni Alliance Pharma (LSE:APH)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Alliance Pharma
Grafico Azioni Alliance Pharma (LSE:APH)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Alliance Pharma